We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LGND icon
451
Ligand Pharmaceuticals
LGND
$5.96B
$2.04M 0.03%
+24,045
New +$2.56M
APH icon
452
Amphenol
APH
$182B
$2.02M 0.03%
99,908
-6,652
-6% -$143K
TROW icon
453
T. Rowe Price
TROW
$25.4B
$2M 0.03%
21,717
-2,839
-12% -$276K
EIDX
454
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$2M 0.03%
+145,000
New +$1.83M
EGL
455
DELISTED
Engility Holdings, Inc.
EGL
$1.98M 0.03%
69,669
– –
PFG icon
456
Principal Financial Group
PFG
$23.9B
$1.98M 0.03%
44,821
-3,939
-8% -$194K
NTAP icon
457
NetApp
NTAP
$33.2B
$1.97M 0.03%
32,982
-125,124
-79% -$9M
STT icon
458
State Street
STT
$50.3B
$1.97M 0.03%
31,163
+645
+2% +$46.2K
L icon
459
Loews
L
$24.4B
$1.95M 0.03%
42,914
+2,727
+7% +$129K
CNQ icon
460
Canadian Natural Resources
CNQ
$93.6B
$1.94M 0.03%
163,846
+29
+0% +$390
CPB icon
461
Campbell Soup
CPB
$6.74B
$1.92M 0.03%
58,204
-25,306
-30% -$957K
AVB icon
462
AvalonBay Communities
AVB
$27B
$1.92M 0.03%
11,026
+519
+5% +$93.8K
MFC icon
463
Manulife Financial
MFC
$72.9B
$1.91M 0.03%
134,389
-25,418
-16% -$403K
ORLY icon
464
O'Reilly Automotive
ORLY
$75.7B
$1.87M 0.03%
81,465
-5,145
-6% -$117K
DGX icon
465
Quest Diagnostics
DGX
$25.5B
$1.85M 0.03%
22,273
+7,584
+52% +$711K
INFY icon
466
Infosys
INFY
$47.3B
$1.84M 0.03%
193,606
+85,126
+78% +$813K
DRI icon
467
Darden Restaurants
DRI
$23.3B
$1.83M 0.03%
18,363
+5,093
+38% +$545K
LNG icon
468
Cheniere Energy
LNG
$54.3B
$1.82M 0.03%
30,735
+11,306
+58% +$696K
RCI icon
469
Rogers Communications
RCI
$17.8B
$1.82M 0.03%
35,484
-484
-1% -$25.1K
AZO icon
470
AutoZone
AZO
$50.4B
$1.79M 0.03%
2,140
-243
-10% -$195K
DOV icon
471
Dover
DOV
$27.4B
$1.77M 0.03%
24,968
-1,603
-6% -$131K
DOVA
472
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$1.77M 0.03%
233,200
– –
MCK icon
473
McKesson
MCK
$100B
$1.75M 0.03%
15,867
-29,417
-65% -$3.67M
ALV icon
474
Autoliv
ALV
$8.7B
$1.73M 0.03%
24,638
+816
+3% +$66.2K
TDG icon
475
TransDigm Group
TDG
$71.8B
$1.72M 0.03%
5,051
-422
-8% -$145K
17 18
19
20 21

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.